Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Ixempra (Ixapebilone) – New Cancer Therapy



Tumour cells spread from the primary site

The mechanism by which tumour cells spread from the primary site via blood and lymph to other sits in the body.

  • Structure of the breast and mammary gland
    Structure of the breast and mammary gland.
  • The most common cancers diagnosed in women in the UK
    The most common cancers diagnosed in women in the UK in 2001 out of a total...
  • Tumour cells spread from the primary site
    The mechanism by which tumour cells spread from the primary site via blood...
  • advanced breast cancer sites
    Diagram showing the most likely sites for local and distant spread of...
  • Tumour cells develop resistance to chemotherapeutic agents
    An illustration of how tumour cells develop resistance to chemotherapeutic...
  • Microtubule inhibitor that stops cells separating during the G2 phase
    Ixabepilone is a microtubule inhibitor that stops cells separating during the...

Back to Project Details



Related Projects

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Avastin (bevacizumab) - Angiogenesis
The product of a joint development programme between Genentech and...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.